American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

Edwards Lifesciences Corp

EW Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

EW historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of EW by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Aug 03, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 27, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 15, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 May 01, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Apr 24, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 13, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Mar 30, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 23, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 05, 2026
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov 19, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Oct 07, 2025
Jefferson Shreve House / R Sale $50,001 - $100,000 May 12, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Apr 21, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Apr 08, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Apr 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 03, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Byron Donalds House / R Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Markwayne Mullin Senate / R Sale (Partial) $15,001 - $50,000 Aug 20, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Mike Kelly House / R Sale $1,001 - $15,000 Apr 11, 2024
Ro Khanna House / D Purchase None N/A
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec 11, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
John R. Curtis House / R Sale $1,001 - $15,000 Dec 04, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 06, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Nov 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 03, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Markwayne Mullin Senate / R Purchase $1,001 - $15,000 Oct 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Sep 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 28, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Jun 21, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May 25, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Apr 26, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 25, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Apr 03, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar 06, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 02, 2022
EW Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
EW Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EW Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in EW holdings by institutional investors

Insider Trading

Quarterly net insider trading by EW's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $280,000 Jul 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $340,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $350,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $280,000 Oct 20, 2025 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid
  • $360,000 Jul 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $350,000 Apr 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans
  • $390,000 Jan 17, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $350,000 Oct 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $370,000 Aug 26, 2024 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Jul 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $330,000 Oct 17, 2023 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $350,000 Jan 17, 2023 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $310,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $330,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Apr 27, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $260,000 Apr 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $340,000 Jan 20, 2022 Issue: None
  • $290,000 Oct 20, 2021 Issue: None
  • $240,000 Jul 20, 2021 Issue: None
  • $240,000 Apr 19, 2021 Issue: None
  • $310,000 Jan 20, 2021 Issue: None
  • $230,000 Oct 19, 2020 Issue: None
  • $360,000 Jul 20, 2020 Issue: None
  • $340,000 Apr 20, 2020 Issue: None
  • $340,000 Jan 21, 2020 Issue: None
  • $250,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $380,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $350,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $310,000 May 13, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Oct 08, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $390,000 Jul 31, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Apr 16, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $190,000 Oct 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Apr 17, 2017 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $180,000 Jan 17, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $220,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Apr 19, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $190,000 Jan 19, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $260,000 Jul 20, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $340,000 Apr 17, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $200,000 Jan 19, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $210,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $230,000 Jul 18, 2014 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans Medicare/Medicaid
  • $250,000 Apr 21, 2014 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $220,000 Jan 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $300,000 Jul 19, 2013 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Trade (domestic/foreign)
  • $360,000 Apr 19, 2013 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $280,000 Jan 18, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $270,000 Oct 18, 2012 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $240,000 Jul 20, 2012 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $360,000 Apr 20, 2012 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $230,000 Jan 19, 2012 Issue: Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $250,000 Oct 20, 2011 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Taxation/Internal Revenue Code
  • $290,000 Jul 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $320,000 Apr 20, 2011 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Transportation
  • $240,000 Jan 20, 2011 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $210,000 Oct 20, 2010 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $250,000 Jul 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $290,000 Apr 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Jan 20, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Health Issues Trade (domestic/foreign) Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Oct 19, 2009 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Torts Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $300,000 Jul 20, 2009 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Medicare/Medicaid Medical/Disease Research/Clinical Labs Torts
  • $180,000 Apr 28, 2009 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $270,000 Apr 28, 2009 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Trade (domestic/foreign) Agriculture Health Issues Budget/Appropriations
  • $115,817 Oct 20, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $178,357 Aug 13, 2008 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Agriculture Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $141,053 Jul 21, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $186,280 Feb 14, 2008 Issue: Trade (domestic/foreign) Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
  • $118,278 Aug 07, 2007 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations
  • $98,785 Jan 30, 2007 Issue: Medicare/Medicaid Agriculture
  • $93,556 Aug 08, 2006 Issue: Agriculture Medicare/Medicaid
  • $21,000 Feb 24, 2006 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $20,000 Nov 21, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $117,500 Aug 17, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid
Revolving Door

Former government officials who have lobbied for EW

33 former government officials from 18 congressional offices at 8 lobbying firms have lobbied for EW, most recently Jul 20, 2026.

  • Bill Cassidy
    Robb Walton Senate Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes Formerly with Bill Cassidy · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Tom Bliley
    Brent Del Monte House Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee Formerly with Tom Bliley · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Elizabeth Warren
    Remy Mason Senate Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz Formerly with Elizabeth Warren · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • John Stone House Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C Formerly Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Debbie Wasserman Schultz
    Daniel Farmer House Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space Formerly with Debbie Wasserman Schultz · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Jimmy Panetta
    Joel Bailey House COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall Formerly with Jimmy Panetta · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Ron Wyden
    Raghav Aggarwal Senate Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior Formerly with Ron Wyden · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Marsha Blackburn
    Chris Kelly Senate Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn Formerly with Marsha Blackburn · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
See all 33 on the Revolving Door dashboard
Corporate Lobbying

EW Estimated quarterly lobbying spending

Revenue Breakdown

EW Revenue by Segment or Geography

By Segment
By Geography
EW Income Statement
EW Balance Sheet
EW Cash Flow
U.S. Patents

New EW patent grants

  • Patent Title: Textured woven fabric for use in implantable bioprostheses Jul. 14, 2026
  • Patent Title: Clamp Jul. 14, 2026
  • Patent Title: Prosthetic valve and holder Feb. 10, 2026
  • Patent Title: Dry packaging for heart valve Dec. 16, 2025
  • Patent Title: Cradle Nov. 11, 2025
  • Patent Title: Catheter clamping device Sep. 30, 2025
  • Patent Title: Handle for implant delivery device Jul. 15, 2025
  • Patent Title: Cradle Apr. 15, 2025
  • Patent Title: Heart valve docking coil Jan. 07, 2025
  • Patent Title: Leaflet for a prosthetic heart valve Dec. 17, 2024
  • Patent Title: Prosthetic valve and holder Sep. 24, 2024
  • Patent Title: Stent Aug. 13, 2024
  • Patent Title: Base Aug. 13, 2024
  • Patent Title: Medical device electronic connector plug Aug. 13, 2024
  • Patent Title: Collapsible heart valve sizer Aug. 15, 2023
  • Patent Title: Expanded heart valve stent Feb. 21, 2023
  • Patent Title: Stent Jan. 31, 2023
  • Patent Title: Prosthetic valve and holder Aug. 09, 2022
  • Patent Title: Bracket with clips May. 17, 2022
  • Patent Title: Collapsible heart valve sizer May. 17, 2022
  • Patent Title: Expanded heart valve stent Feb. 22, 2022
  • Patent Title: Prosthetic valve and holder Oct. 12, 2021
  • Patent Title: Collapsible heart valve sizer Jul. 06, 2021
  • Patent Title: Collapsible heart valve sizer Jan. 26, 2021
  • Patent Title: Prosthetic heart valve Aug. 11, 2020
  • Patent Title: Heart valve docking coil Jul. 14, 2020
  • Patent Title: Stent Nov. 19, 2019
  • Patent Title: Prosthetic heart valve Nov. 19, 2019
  • Patent Title: Prosthetic valve with ventricular tethers Jul. 09, 2019
  • Patent Title: Heart valve sizer Apr. 16, 2019
  • Patent Title: Suture securement devices Jan. 22, 2019
  • Patent Title: Heart valve holder and method for resisting suture looping Oct. 02, 2018
  • Patent Title: System and method for treating valve insufficiency or vessel dilatation Jun. 19, 2018
  • Patent Title: Devices, systems and methods for accurate positioning of a prosthetic valve Jun. 19, 2018
  • Patent Title: Single catheter heart repair device and method for use Jun. 19, 2018
  • Patent Title: Methods for retaining a prosthetic heart valve Jun. 12, 2018
  • Patent Title: Finger-mounted surgical instruments and methods of use Jun. 12, 2018
  • Patent Title: Expandable sheath for introducing an endovascular delivery device into a body Jun. 05, 2018
  • Patent Title: Bi-directional cannula May. 29, 2018
  • Patent Title: Prosthetic heart valve system with positioning markers May. 29, 2018
  • Patent Title: Prosthetic heart valve, system, and method May. 29, 2018
  • Patent Title: Low profile transcatheter heart valve May. 22, 2018
  • Patent Title: Prosthetic heart valve May. 22, 2018
  • Patent Title: Cardiac implant with integrated suture fasteners May. 15, 2018
  • Patent Title: Methods for ensuring safe and rapid deployment of prosthetic heart valves May. 15, 2018
  • Patent Title: Cardiac shunt Feb. 20, 2018
  • Patent Title: Heart valve holder and method for resisting suture looping Jan. 16, 2018
  • Patent Title: In-line blood sampling accessory Jan. 25, 2011
  • Patent Title: In-line blood sampling accessory May. 25, 2010
  • Patent Title: Sensor case Jan. 19, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to EW from public contracts

EW News

Recent insights relating to EW

CNBC Recommendations

Recent picks made for EW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EW

EW Analyst Ratings

EW Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EW Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EW stock a Buy, Sell, or Hold?

  • What is the price target for $EW stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EW Top Shareholders
Shareholder
Shares Held
EW Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EW stock?

  • Who owns the most shares of $EW stock?

  • What funds own $EW stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EW Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EW Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

  • Address Irvine, CA
  • Market Cap 51.2 billion
  • Employees 16,000
  • Industrial Classification Orthopedic, Prosthetic & Surgical Appliances & Supplies

Edwards Lifesciences Corp (EW) Historical Stock Prices

Edwards Lifesciences Corp (EW) closed at $88.78 on September 22, 2026. Over the past year its adjusted close ranged from $72.65 to $95.18. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-1.12%
  • 3 months+2.10%
  • Year to date+4.14%
  • 1 year+20.38%
  • 3 years+27.45%
  • 5 years-26.64%
  • Max+708.05%
See every congressional and insider trade on the EW price chart

Quiver Premium charts EW's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 89.00 89.66 88.50 88.78 88.78 3,534,102
Sep 21, 2026 88.34 88.59 87.77 88.34 88.34 3,347,115
Sep 18, 2026 88.03 88.77 87.47 88.26 88.26 4,258,353
Sep 17, 2026 89.21 89.58 88.00 88.25 88.25 3,880,110
Sep 16, 2026 84.99 89.70 84.84 89.28 89.28 5,011,766
Sep 15, 2026 85.03 86.03 84.47 85.74 85.74 3,777,847
Sep 14, 2026 85.45 86.26 85.12 85.52 85.52 2,988,117
Sep 11, 2026 87.51 87.75 83.81 84.37 84.37 3,795,193
Sep 10, 2026 86.00 87.27 85.00 86.77 86.77 2,310,829
Sep 9, 2026 86.27 87.04 85.73 86.18 86.18 2,736,837
Sep 8, 2026 89.07 89.09 86.39 86.72 86.72 3,583,538
Sep 4, 2026 90.21 90.21 88.40 89.90 89.90 2,635,295
Sep 3, 2026 91.08 91.53 89.33 89.78 89.78 1,844,143
Sep 2, 2026 91.47 92.36 90.55 90.82 90.82 2,595,780
Sep 1, 2026 91.39 92.95 90.10 90.74 90.74 2,539,929
Aug 31, 2026 91.00 91.29 89.31 90.75 90.75 4,047,531
Aug 28, 2026 89.98 90.41 89.55 90.21 90.21 2,043,703
Aug 27, 2026 90.78 91.48 89.79 89.95 89.95 3,059,265
Aug 26, 2026 90.29 92.12 90.08 90.78 90.78 2,778,784
Aug 25, 2026 90.38 91.27 89.68 90.87 90.87 2,389,753
Aug 24, 2026 89.89 91.11 89.46 90.50 90.50 2,722,012
Aug 21, 2026 89.89 90.37 88.79 89.79 89.79 2,819,775
Aug 20, 2026 91.61 92.27 89.75 89.83 89.83 2,638,021
Aug 19, 2026 91.47 93.25 91.27 92.28 92.28 3,406,151
Aug 18, 2026 90.96 91.69 90.40 90.98 90.98 2,762,349
Aug 17, 2026 90.84 91.58 90.59 90.81 90.81 2,246,351
Aug 14, 2026 92.92 92.92 91.48 91.60 91.60 2,856,892
Aug 13, 2026 93.48 93.75 92.21 92.56 92.56 2,809,926
Aug 12, 2026 91.66 93.38 91.66 93.05 93.05 2,340,306
Aug 11, 2026 92.03 93.91 91.97 93.66 93.66 3,138,661
Aug 10, 2026 89.38 92.81 88.61 92.03 92.03 4,443,994
Aug 7, 2026 89.44 90.36 88.77 89.72 89.72 2,442,024
Aug 6, 2026 88.98 89.36 87.94 89.32 89.32 2,655,569
Aug 5, 2026 89.70 91.02 88.54 88.97 88.97 3,665,538
Aug 4, 2026 88.50 89.83 88.16 89.60 89.60 4,318,689
Aug 3, 2026 86.89 88.91 86.39 88.82 88.82 3,962,297
Jul 31, 2026 87.08 87.08 85.24 86.07 86.07 3,952,948
Jul 30, 2026 85.41 87.03 85.05 86.92 86.92 3,935,938
Jul 29, 2026 84.79 86.00 82.91 85.76 85.76 5,594,725
Jul 28, 2026 84.60 85.51 83.22 83.68 83.68 5,606,869
Jul 27, 2026 83.30 84.12 81.16 83.04 83.04 6,707,520
Jul 24, 2026 88.00 89.08 82.53 82.63 82.63 10,480,908
Jul 23, 2026 83.52 84.45 82.99 83.82 83.82 6,913,372
Jul 22, 2026 85.22 85.53 84.02 84.37 84.37 4,512,283
Jul 21, 2026 83.99 84.87 83.17 84.55 84.55 5,571,029
Jul 20, 2026 85.97 86.28 84.87 85.00 85.00 3,751,422
Jul 17, 2026 86.96 87.06 85.30 85.73 85.73 5,225,093
Jul 16, 2026 87.89 89.49 86.42 87.84 87.84 5,950,626
Jul 15, 2026 89.22 89.76 86.89 87.27 87.27 8,196,012
Jul 14, 2026 90.48 90.62 88.20 90.09 90.09 5,249,221
Jul 13, 2026 92.28 93.09 91.50 91.79 91.79 3,250,710
Jul 10, 2026 91.70 92.25 90.69 92.21 92.21 3,381,396
Jul 9, 2026 93.05 93.22 91.03 91.33 91.33 5,578,677
Jul 8, 2026 94.43 95.13 92.89 93.64 93.64 3,673,430
Jul 7, 2026 96.10 96.29 94.20 94.82 94.82 4,445,101
Jul 6, 2026 94.36 95.57 92.72 95.18 95.18 3,958,057
Jul 2, 2026 92.07 94.47 91.82 94.37 94.37 3,206,400
Jul 1, 2026 91.01 92.39 90.28 91.99 91.99 4,284,007
Jun 30, 2026 91.53 92.00 89.69 90.46 90.46 3,627,318
Jun 29, 2026 91.02 92.88 91.01 91.18 91.18 3,606,384
Jun 26, 2026 90.31 92.46 89.33 90.78 90.78 14,420,825
Jun 25, 2026 90.12 91.65 89.66 89.72 89.72 4,318,766
Jun 24, 2026 87.35 90.99 87.00 89.66 89.66 4,511,691
Jun 23, 2026 86.19 87.22 85.46 86.95 86.95 4,228,237
Jun 22, 2026 87.34 87.41 85.31 85.88 85.88 3,506,790
Jun 18, 2026 86.96 87.83 86.52 87.36 87.36 5,550,251
Jun 17, 2026 87.92 89.14 86.28 86.68 86.68 5,030,156
Jun 16, 2026 89.02 89.60 87.55 88.58 88.58 5,638,216
Jun 15, 2026 85.30 86.31 84.61 86.28 86.28 2,929,807
Jun 12, 2026 86.48 86.51 83.17 85.11 85.11 4,571,613
Jun 11, 2026 86.05 87.08 85.55 85.76 85.76 5,087,226
Jun 10, 2026 86.59 87.22 85.10 85.98 85.98 4,537,874
Jun 9, 2026 86.27 87.93 85.97 87.54 87.54 3,442,466
Jun 8, 2026 85.99 86.73 84.70 85.85 85.85 4,374,179
Jun 5, 2026 88.24 89.48 84.70 85.96 85.96 5,778,958
Jun 4, 2026 87.38 88.39 86.72 87.45 87.45 4,530,644
Jun 3, 2026 87.63 87.90 85.81 86.00 86.00 4,971,880
Jun 2, 2026 87.60 88.60 86.17 87.66 87.66 6,186,799
Jun 1, 2026 86.55 89.14 86.25 88.16 88.16 7,649,919
May 29, 2026 86.08 88.02 85.83 86.47 86.47 7,270,721
May 28, 2026 86.22 88.02 85.84 85.96 85.96 6,439,524
May 27, 2026 87.63 88.28 85.63 86.51 86.51 7,328,272
May 26, 2026 86.25 87.93 85.52 87.54 87.54 5,116,414
May 22, 2026 83.77 86.03 83.12 85.78 85.78 4,941,924
May 21, 2026 82.13 83.50 81.82 83.20 83.20 3,727,081
May 20, 2026 81.74 83.59 81.22 82.97 82.97 4,029,515
May 19, 2026 82.29 82.61 80.87 82.16 82.16 4,086,804
May 18, 2026 81.14 82.88 80.57 82.39 82.39 4,180,416
May 15, 2026 80.14 82.28 80.14 81.38 81.38 4,672,977
May 14, 2026 81.46 81.94 80.33 81.34 81.34 3,312,552
May 13, 2026 79.55 81.73 78.29 81.39 81.39 5,338,816
May 12, 2026 77.76 79.98 77.35 79.73 79.73 5,075,382
May 11, 2026 79.73 80.08 76.49 77.17 77.17 5,262,032
May 8, 2026 82.89 83.04 79.24 79.96 79.96 4,031,273
May 7, 2026 83.25 84.42 82.65 82.76 82.76 3,332,532
May 6, 2026 82.73 83.59 81.32 83.20 83.20 5,083,742
May 5, 2026 83.95 83.95 81.42 82.91 82.91 3,288,318
May 4, 2026 83.66 84.64 83.15 83.33 83.33 3,302,609
May 1, 2026 84.01 85.06 82.53 83.98 83.98 6,580,877
Apr 30, 2026 81.53 83.63 80.65 83.50 83.50 6,642,925
Apr 29, 2026 81.95 82.28 80.75 81.22 81.22 5,014,697
Apr 28, 2026 84.13 84.95 81.51 82.28 82.28 5,837,725
Apr 27, 2026 83.54 84.79 83.22 83.46 83.46 7,167,720
Apr 24, 2026 82.50 84.74 82.12 84.15 84.15 11,816,695
Apr 23, 2026 81.53 82.00 79.19 79.72 79.72 6,234,321
Apr 22, 2026 80.14 81.72 79.92 81.53 81.53 4,943,851
Apr 21, 2026 81.48 81.84 79.30 79.71 79.71 4,881,401
Apr 20, 2026 80.95 82.49 80.50 81.44 81.44 5,510,835
Apr 17, 2026 78.79 81.69 78.79 80.99 80.99 5,555,455
Apr 16, 2026 77.68 79.23 77.26 79.05 79.05 6,192,791
Apr 15, 2026 78.52 78.95 77.10 78.20 78.20 5,128,511
Apr 14, 2026 77.84 78.90 77.33 78.20 78.20 5,859,782
Apr 13, 2026 77.57 78.17 77.20 78.12 78.12 6,303,264
Apr 10, 2026 79.15 79.85 77.50 77.87 77.87 4,946,414
Apr 9, 2026 81.32 81.32 79.06 79.15 79.15 5,469,210
Apr 8, 2026 82.02 82.77 81.36 81.71 81.71 4,664,051
Apr 7, 2026 80.62 81.41 80.21 80.84 80.84 4,014,792
Apr 6, 2026 81.00 81.72 80.56 81.19 81.19 2,377,061
Apr 2, 2026 81.14 81.72 79.40 81.05 81.05 3,303,023
Apr 1, 2026 81.00 82.17 80.11 81.26 81.26 5,357,191
Mar 31, 2026 80.01 80.53 77.60 80.08 80.08 4,426,338
Mar 30, 2026 79.19 80.63 78.39 79.50 79.50 4,911,489
Mar 27, 2026 81.80 81.84 78.56 79.34 79.34 4,873,944
Mar 26, 2026 82.36 83.76 81.93 82.10 82.10 6,235,043
Mar 25, 2026 82.44 83.09 81.28 82.67 82.67 3,639,573
Mar 24, 2026 81.65 82.33 80.60 81.69 81.69 3,899,852
Mar 23, 2026 82.50 83.83 81.86 82.02 82.02 4,411,861
Mar 20, 2026 81.86 83.04 81.86 82.50 82.50 4,358,664
Mar 19, 2026 82.43 83.62 81.73 82.46 82.46 4,033,950
Mar 18, 2026 83.45 84.03 82.59 82.61 82.61 3,510,682
Mar 17, 2026 83.65 85.14 83.34 84.27 84.27 4,220,287
Mar 16, 2026 82.13 84.25 81.89 83.56 83.56 4,270,713
Mar 13, 2026 85.13 85.33 81.34 81.81 81.81 5,617,688
Mar 12, 2026 84.96 85.51 83.18 84.61 84.61 4,223,959
Mar 11, 2026 86.11 86.11 83.84 85.09 85.09 4,313,499
Mar 10, 2026 83.99 86.38 82.88 85.78 85.78 6,265,811
Mar 9, 2026 80.87 84.29 80.54 84.26 84.26 4,758,656
Mar 6, 2026 83.00 83.08 80.50 81.64 81.64 5,223,769
Mar 5, 2026 84.44 84.83 82.97 83.89 83.89 6,404,836
Mar 4, 2026 85.14 85.81 84.22 85.22 85.22 4,439,290
Mar 3, 2026 85.87 86.56 83.76 85.28 85.28 5,594,225
Mar 2, 2026 85.67 87.32 85.60 87.18 87.18 3,749,413
Feb 27, 2026 85.76 86.95 85.20 86.47 86.47 6,172,765
Feb 26, 2026 83.85 85.92 83.67 85.90 85.90 3,707,894
Feb 25, 2026 82.64 84.07 82.56 83.40 83.40 4,187,494
Feb 24, 2026 82.33 83.03 81.17 82.40 82.40 4,486,693
Feb 23, 2026 79.10 82.77 79.10 82.44 82.44 5,498,688
Feb 20, 2026 78.60 79.93 78.00 79.78 79.78 4,735,971
Feb 19, 2026 78.50 79.12 77.66 78.92 78.92 2,610,066
Feb 18, 2026 78.39 79.08 77.72 78.98 78.98 4,116,910
Feb 17, 2026 77.21 80.42 76.33 78.45 78.45 6,112,295
Feb 13, 2026 76.62 77.56 75.51 75.87 75.87 5,346,368
Feb 12, 2026 79.29 79.63 76.06 76.44 76.44 5,382,620
Feb 11, 2026 78.61 79.91 74.66 79.33 79.33 11,285,591
Feb 10, 2026 76.90 78.23 76.37 77.05 77.05 6,561,748
Feb 9, 2026 78.13 78.38 76.52 76.80 76.80 6,110,949
Feb 6, 2026 78.70 78.89 77.44 78.71 78.71 6,476,700
Feb 5, 2026 79.87 80.66 77.46 78.10 78.10 6,989,058
Feb 4, 2026 81.48 81.98 79.62 79.77 79.77 6,461,778
Feb 3, 2026 82.38 83.77 82.00 82.10 82.10 3,389,755
Feb 2, 2026 81.44 82.89 81.04 82.65 82.65 3,779,061
Jan 30, 2026 81.60 82.82 80.75 81.36 81.36 3,703,871
Jan 29, 2026 82.46 82.53 80.44 81.49 81.49 4,096,038
Jan 28, 2026 83.09 83.68 81.81 81.86 81.86 2,742,778
Jan 27, 2026 84.01 84.69 83.16 83.60 83.60 2,022,858
Jan 26, 2026 83.36 84.56 83.25 84.27 84.27 3,027,410
Jan 23, 2026 84.36 85.00 83.40 83.66 83.66 3,192,087
Jan 22, 2026 85.24 86.19 84.31 84.44 84.44 3,821,534
Jan 21, 2026 83.92 85.69 83.69 85.14 85.14 5,043,279
Jan 20, 2026 83.72 85.16 82.82 83.46 83.46 4,000,794
Jan 16, 2026 84.17 84.55 83.27 84.35 84.35 3,454,404
Jan 15, 2026 83.50 84.51 82.38 84.49 84.49 3,103,907
Jan 14, 2026 83.32 83.60 81.26 83.10 83.10 6,290,378
Jan 13, 2026 83.00 83.95 82.56 83.84 83.84 4,061,253
Jan 12, 2026 86.00 86.10 82.56 83.01 83.01 3,245,240
Jan 9, 2026 85.28 86.05 84.72 85.13 85.13 3,383,855
Jan 8, 2026 84.28 85.53 84.25 84.58 84.58 3,738,686
Jan 7, 2026 86.27 86.60 83.93 84.83 84.83 4,287,234
Jan 6, 2026 84.39 86.56 84.33 85.85 85.85 3,811,876
Jan 5, 2026 85.00 85.33 83.66 84.17 84.17 4,207,214
Jan 2, 2026 85.46 85.48 84.08 85.33 85.33 2,377,028
Dec 31, 2025 86.03 86.64 85.19 85.25 85.25 1,569,610
Dec 30, 2025 86.63 87.06 86.12 86.20 86.20 1,635,450
Dec 29, 2025 87.00 87.44 86.72 86.94 86.94 1,600,893
Dec 26, 2025 86.41 86.87 85.80 86.85 86.85 914,931
Dec 24, 2025 86.10 86.50 85.79 86.29 86.29 704,791
Dec 23, 2025 86.10 86.53 85.82 86.23 86.23 1,743,004
Dec 22, 2025 85.50 86.98 84.87 86.53 86.53 2,412,549
Dec 19, 2025 85.18 85.82 84.84 85.66 85.66 7,253,411
Dec 18, 2025 85.83 86.07 84.64 84.80 84.80 3,020,984
Dec 17, 2025 85.76 86.19 84.67 84.84 84.84 3,900,356
Dec 16, 2025 83.16 85.75 82.31 85.32 85.32 5,950,339
Dec 15, 2025 83.57 84.09 81.85 83.38 83.38 4,014,780
Dec 12, 2025 84.12 84.50 83.03 83.08 83.08 2,855,746
Dec 11, 2025 84.35 84.60 83.64 84.24 84.24 2,104,149
Dec 10, 2025 83.45 84.41 83.35 83.92 83.92 2,898,619
Dec 9, 2025 84.59 85.19 83.08 83.28 83.28 2,412,585
Dec 8, 2025 86.01 86.01 84.16 84.32 84.32 3,579,252
Dec 5, 2025 86.31 87.89 85.94 86.19 86.19 3,461,311
Dec 4, 2025 84.12 85.96 83.98 85.78 85.78 3,612,707
Dec 3, 2025 84.73 85.05 83.94 83.98 83.98 2,271,443
Dec 2, 2025 85.35 85.35 83.60 84.71 84.71 3,339,401
Dec 1, 2025 86.60 86.93 85.17 85.27 85.27 2,644,474
Nov 28, 2025 87.08 87.19 86.36 86.67 86.67 1,345,292
Nov 26, 2025 86.80 87.40 86.55 86.75 86.75 2,176,036
Nov 25, 2025 84.66 86.94 84.66 86.82 86.82 3,156,902
Nov 24, 2025 84.88 85.56 83.81 84.71 84.71 7,729,245
Nov 21, 2025 84.38 85.66 84.28 85.13 85.13 4,848,919
Nov 20, 2025 86.02 86.86 84.02 84.09 84.09 3,595,029
Nov 19, 2025 84.04 86.03 83.32 86.02 86.02 4,473,390
Nov 18, 2025 85.05 85.66 84.03 84.04 84.04 3,334,058
Nov 17, 2025 85.92 86.54 84.66 84.74 84.74 3,798,529
Nov 14, 2025 86.29 86.68 84.74 86.30 86.30 3,269,797
Nov 13, 2025 85.08 87.20 84.94 86.11 86.11 4,444,700
Nov 12, 2025 85.24 85.96 85.03 85.58 85.58 3,052,876
Nov 11, 2025 84.43 85.40 84.31 85.16 85.16 2,639,680
Nov 10, 2025 82.55 84.16 82.01 84.08 84.08 3,140,301
Nov 7, 2025 82.87 83.82 82.26 83.39 83.39 3,160,461
Nov 6, 2025 82.89 82.97 81.69 82.44 82.44 3,137,959
Nov 5, 2025 84.05 84.54 82.53 82.84 82.84 3,880,651
Nov 4, 2025 83.05 84.83 82.89 84.15 84.15 4,557,608
Nov 3, 2025 83.41 83.75 80.24 83.07 83.07 6,170,559
Oct 31, 2025 84.48 87.09 81.49 82.45 82.45 11,511,970
Oct 30, 2025 82.95 83.71 82.35 83.48 83.48 6,525,239
Oct 29, 2025 84.50 84.66 81.80 82.69 82.69 6,199,136
Oct 28, 2025 80.17 83.25 79.85 82.19 82.19 9,813,904
Oct 27, 2025 76.00 83.04 75.48 80.82 80.82 13,100,215
Oct 24, 2025 76.89 77.16 76.09 76.10 76.10 3,165,672
Oct 23, 2025 76.53 76.86 75.75 76.53 76.53 3,145,839
Oct 22, 2025 76.80 78.33 76.22 76.84 76.84 6,028,204
Oct 21, 2025 75.09 76.09 74.69 76.02 76.02 3,792,157
Oct 20, 2025 74.69 75.57 74.43 75.29 75.29 4,178,988
Oct 17, 2025 72.75 74.81 72.67 74.64 74.64 4,955,803
Oct 16, 2025 73.01 73.78 72.42 72.65 72.65 2,634,807
Oct 15, 2025 72.77 73.83 72.40 72.93 72.93 4,330,015
Oct 14, 2025 72.77 73.52 72.47 73.36 73.36 3,508,590
Oct 13, 2025 73.17 73.69 72.30 72.95 72.95 3,937,513
Oct 10, 2025 75.13 75.23 73.91 73.94 73.94 3,757,667
Oct 9, 2025 75.77 75.88 74.72 75.19 75.19 3,181,011
Oct 8, 2025 74.50 75.79 73.16 75.74 75.74 5,601,315
Oct 7, 2025 77.85 78.04 76.54 76.72 76.72 2,993,985
Oct 6, 2025 77.13 78.00 76.47 76.56 76.56 2,882,125
Oct 3, 2025 76.65 77.97 76.50 77.07 77.07 4,620,539
Oct 2, 2025 75.48 76.72 74.51 76.65 76.65 3,768,467
Oct 1, 2025 77.79 78.37 73.90 76.31 76.31 5,994,646
Sep 30, 2025 77.14 78.15 76.78 77.77 77.77 3,783,852
Sep 29, 2025 76.34 77.74 75.80 77.19 77.19 4,909,259
Sep 26, 2025 75.56 76.38 75.35 76.25 76.25 4,477,705
Sep 25, 2025 74.50 75.53 73.70 75.27 75.27 6,333,110
Sep 24, 2025 74.31 75.30 74.02 74.66 74.66 3,491,007
Sep 23, 2025 73.69 75.30 73.23 74.57 74.57 5,445,169
Sep 22, 2025 74.20 74.56 73.38 73.75 73.75 3,670,260

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Edwards Lifesciences Corp Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at EW, per a recent SEC DEF 14A filing. We estimate that the median employee at Edwards Lifesciences Corp is paid $74,125.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation